PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2011 by Amgen.
Recruitment status was Active, not recruiting

Sponsor:

Information provided by:

Amgen

ClinicalTrials.gov Identifier:

NCT00446446

First received: March 8, 2007

Last updated: January 20, 2011

Last verified: January 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2011
Estimated Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)